Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Ortho Evra

Ortho-Evra is a transdermal patch that contains both an estrogen (20 meg of ethinyl estradiol) and a progestin (150 meg... [Pg.746]

A combination contraceptive is available as a transdermal patch (Ortho Evra), which may have improved adherence compared to OCs. Efficacy seems to be compromised in women over 198 lb (90 kg). The patch should be applied to the abdomen, buttocks, upper torso, or upper arm at the beginning of the menstrual cycle and replaced every week for 3 weeks. [Pg.351]

Patch 6 mg norelgestromin, 0.75 mg ethinyl estradiol/total patch content (Rx) Ortho Evra (Ortho-McNeil)... [Pg.198]

Ethinyl Estradiol Norelgestromin (Ortho Evra) Etonogestrel subdermal Implant (Implanon)... [Pg.52]

Nonoral contraceptives Ethinyl estradiol Norelgestromin Ortho Evra (transdermal patch)... [Pg.451]

Ortho-McNeil Pharmaceutical, Inc. Ortho Evra (Norel-gestromin/Ethinyl Estradiol Trans dermal System). Raritan, NJ Ortho-McNeil, 2001. [Pg.184]

Ortho Evra Ethinyl estradiol/norelgestromin Contraception Ortho-Mcneil... [Pg.794]

Estraderm (Novartis), Vivelle (Novartis), Climara (Berlex) Testoderm (Alza), Androderm (SmithKline Beecham) CombiPatch (Noven/Aventis), Ortho-Evra Progestersert (Alza)... [Pg.282]

Ethinyloestradiol (EE) Ortho Evra patch Abdomen application is not bioequivalent, but therapeutically equivalent to that applied at the other sites. ... [Pg.3817]

Abrams, L.S. Skee, D.M. Natarajan, J. Wong, F.A. Leese, P.T. Creasy, G.W. Shangold, M.M. Pharmacokinetics of norelgestromin and ethinH estradiol delivered by a contraceptive patch (Ortho Evra /Evra) under conditions of heat humidity, and exercise. J. Clin. Pharmacol. 2001, 41, 1301-1309. [Pg.3826]

Norelgestromin. USP. Norelgestromin, (17contraceptive patch (Ortho-Evra). First-pass metaboli.sm in the liver is avoided by the transdermal application. Hepatic metabolism does occur, however, and norgestrel. an active tnetabolite, and other hydroxylated and conjugated metabolites are formed. [Pg.789]

Archer, D.F., Cullins, V., Creasy, D.W. and Fisher, A.C. (2004) The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy . Contraception. 69, 189-195. [Pg.134]

A new combination contraceptive is available as a transdermal patch (Ortho Evra), which includes 0.75 mg EE and 6 mg norelgestromin, the active metabolite of norgestimate. In comparative trials, it has been shown to be as effective as combined OCs. Of the 15 pregnancies reported with the patch, 5 were among women with a baseline weight of greater than 90 kg, so efficacy may be compromised as weight increases. Some patients experience application-site reactions, but other side effects are similar to OCs (i.e., breast discomfort, headache, nausea, and menstrual cramps). [Pg.1459]

Anonymous. Ortho evra A contraceptive patch. Med Lett Drugs Ther 2002 44 8. [Pg.1463]

Sicat BL. Ortho evra, a new contraceptive patch. Pharmacotherapy 2003 23 472 80. [Pg.1463]

Zieman M, Guillebaud J, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system the analysis of pooled data. Fertil Steril 2002 77(2 Suppl. 2) S13-S18. [Pg.2111]

See other pages where Ortho Evra is mentioned: [Pg.740]    [Pg.746]    [Pg.159]    [Pg.66]    [Pg.69]    [Pg.257]    [Pg.159]    [Pg.44]    [Pg.45]    [Pg.45]    [Pg.171]    [Pg.313]    [Pg.793]    [Pg.802]    [Pg.802]    [Pg.455]    [Pg.58]    [Pg.1447]    [Pg.448]    [Pg.1042]    [Pg.1008]    [Pg.159]    [Pg.2084]    [Pg.2088]    [Pg.442]   
See also in sourсe #XX -- [ Pg.746 ]

See also in sourсe #XX -- [ Pg.69 ]



SEARCH



© 2024 chempedia.info